Collaboration combines Scipher’s unique RNAseq data, part of the largest non-oncology clinico-transcriptomic data lake and biobank, with InnoSIGN’s proprietary Comprehensive Pathway Analysis (CPA) platform to enhance the understanding of complex...
The partnership integrates Kythera’s enriched high-fidelity multi-source EHR and claims data assets with real-world clinical and genomic data from Scipher’s PrismRA® Test, revealing new insights for precision medicine advancements. Waltham, MA-April 15, 2025 – Scipher...
Waltham, MA – Jan. 13, 2025 – Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Roivant, a global biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that...
The partnership integrates transcriptome genomic data from Scipher’s PrismRA Test into OMNY’s EMR network, unlocking deeper patient insights for precision medicine advancements. Atlanta, Georgia – Jan. 9, 2025 – OMNY Health, the leading healthcare...
WALTHAM, Mass., December 18, 2024 Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence, today announced a strategic partnership to...
WALTHAM, Mass., July 30, 2024 Scipher Medicine, a company focused on proprietary AI and network biology platform solutions to transform patient care, has launched a new approach to develop biomarkers following the publication of the novel, patent-pending...
